Meeting NewsVideo

VIDEO: Allegro preps to move into phase 3 trial with DME treatment

NEWPORT BEACH, Calif. — Vicken Karageozian, MD, president and chief medical officer for Allegro Ophthalmics, discusses the progress of the company’s product Luminate, which is moving into phase 3 trials for the treatment of diabetic macular edema.

NEWPORT BEACH, Calif. — Vicken Karageozian, MD, president and chief medical officer for Allegro Ophthalmics, discusses the progress of the company’s product Luminate, which is moving into phase 3 trials for the treatment of diabetic macular edema.

    See more from OCTANe Ophthalmology Technology Summit